Sbir topic 107 reagents for immunologic analysis of non- mammalian and underrepresented mammalian models
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93022C00044
- Awardee
-
Ampersand Biosciences LLC UEI HLWQXLFM7JR8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $596,519
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20221 · Posted Jul 12, 2021
- Contract value 100% obligated
- $596,519.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- UPPER ST REG, NY 12945, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $596,519 |
About this award
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to better understand, treat, and prevent infectious diseases. The contract has no set-aside designation and is a definitive contract with an ultimate completion date of December 15, 2024. This contract award is part of a larger SBIR solicitation issued by NIAID and the Centers for Disease Control and Prevention, which included over 100 research topics across various infectious disease, cancer, aging, and public health focus areas.
Quick answers
Who was awarded contract 75N93022C00044?
75N93022C00044 was awarded to Ampersand Biosciences LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2022.
How much is contract 75N93022C00044 worth?
The government has obligated $596,519 on 75N93022C00044.
Was contract 75N93022C00044 competed?
The extent of competition for 75N93022C00044 was full and open competition. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award